Metoprolol Tartrate Tablets Recalled Nationwide for Metal Contamination
Rubicon Research is recalling 11,664 bottles of Metoprolol Tartrate 25mg tablets nationwide due to the presence of metal in the tablets. Consumers should discontinue use and contact their healthcare provider.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall involving physical contamination (metal in tablets). No illnesses or injuries have been reported in the source. Per the rubric, recalls of risk-of-harm products where injury has not yet been reported score 3 (High).
Plain-English summary
Rubicon Research Private Limited is recalling Metoprolol Tartrate Tablets USP, 25mg, in 1000-count bottles distributed nationwide due to the presence of metal in the tablets.
The recalled product is Lot 231037H1 with an expiration date of 6/2027. A total of 11,664 bottles were distributed nationwide. The tablets were manufactured by Rubicon Research Private Limited (Ambernath Dist Thane 421506 India) and distributed by TruPharma, LLC (Tampa, FL).
Affected consumers should discontinue use of this medication and contact their pharmacy or healthcare provider for guidance on obtaining replacement medication. Healthcare providers and pharmacists should identify and quarantine remaining stock of the affected lot.
The recalled product
- Product
- METOPROLOL TARTRATE (METOPROLOL TARTRATE)
- Brand
- METOPROLOL TARTRATE
- Manufacturer
- Rubicon Research Private Limited
- Category
- Drug
- Hazard
- metal-contamination
- foreign-object
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot 231037H1
- exp 6/2027
UPCs (10)
- 0352817361103
- 0352817361004
- 0352817360106
- 0352817362100
- 0352817358509
- 0352817359506
- 0352817362001
- 0352817360007
- 0352817358103
- 0352817359100
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · METOPROLOL TARTRATE
- HighMetoprolol Tartrate Tablets Recalled for Nitrosamine Contamination Above Safety Limits
FDA (Drugs) · 2025-08-20
- HighMetoprolol Tartrate Tablets Recalled for Nitrosamine Contamination Above Safety Limits
FDA (Drugs) · 2025-08-20
- HighMetoprolol Tartrate Tablets Recalled for Foreign Metal in Tablets
FDA (Drugs) · 2022-01-19
- HighMetoprolol Tartrate Tablets Recalled for Metal Wire Contamination
FDA (Drugs) · 2021-09-29
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27